|
2005-12-29 Realignment Supervisory Board.pdf
|
pdf
|
179 kB
|
|
2005-12-15 Partner Merck starts Phase I for S aureus vaccine.pdf
|
pdf
|
213 kB
|
|
2005-12-09 Signing license agreement with Pelias AG.pdf
|
pdf
|
182 kB
|
|
2005-11-18 TB vaccine enters clinical trials.pdf
|
pdf
|
193 kB
|
|
2005-11-14 Q3 results.pdf
|
pdf
|
182 kB
|
|
2005-11-10 AIP patent ENG.pdf
|
pdf
|
179 kB
|
|
2005-11-02 Milestone payment from Merck for bacterial vaccine candidate.pdf
|
pdf
|
178 kB
|
|
2005-10-24 Intercell appoints Management Board.pdf
|
pdf
|
191 kB
|
|
2005-10-20 Alliance with CDC.pdf
|
pdf
|
144 kB
|
|
2005-09-19 Start Phase III of JE vaccine.pdf
|
pdf
|
153 kB
|
|
2005-08-30 CSL ENG.pdf
|
pdf
|
205 kB
|
|
2005-08-12 Q2 results.pdf
|
pdf
|
207 kB
|
|
2005-08-09 Start of Phase III for JE vaccine approved by EMEA.pdf
|
pdf
|
185 kB
|
|
2005-07-01 Sanofi Pasteur exercises options on bacterial vaccine antigens.pdf
|
pdf
|
168 kB
|
|
2005-06-27 Intercell and SSI join forces with Aeras for TB vaccine.pdf
|
pdf
|
161 kB
|
|
2005-06-14 Grant from US NIH for Intercell to develop biodefense vaccines.pdf
|
pdf
|
153 kB
|
|
2005-05-23 Intercell coordinates development for vaccine against Lyme Borreliosis.pdf
|
pdf
|
165 kB
|
|
2005-05-09 Q1 results.pdf
|
pdf
|
210 kB
|
|
2005-05-03 Recruitment completed for optimization trial of HCV vaccine.pdf
|
pdf
|
194 kB
|
|
2005-03-18 Over-allotment option exercised.pdf
|
pdf
|
178 kB
|
|
2005-03-17 Intercell and Biological E Ltd enter into a strategic alliance.pdf
|
pdf
|
160 kB
|
|
2005-02-28 Intercell shares begin trading on the Vienna Stock Exchange.pdf
|
pdf
|
129 kB
|
|
2005-02-25 Intercell AG prices IPO at EUR 5.50 first trading day 2005-02-28.pdf
|
pdf
|
137 kB
|
|
2005-02-14 Intecell launches IPO.pdf
|
pdf
|
194 kB
|
|
2005-01-17 New Supervisory Board Members.pdf
|
pdf
|
145 kB
|
|
2005-01-10 FDA approves Clinical Development Strategy.pdf
|
pdf
|
180 kB
|
